Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 09-Jan-23 7:02 PM View:  | Apellis Pharmaceuticals, Inc. (APLS) | 05-Jan-23 | Private Sale (Planned) | 2,500 | $48.79 | $121,975.00 | (3%) 97.38K to 94.88K | |
| 02-Dec-22 4:30 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 01-Dec-22 | Private Sale (Planned) | 2,500 | $49.93 | $124,825.00 | (3%) 99.88K to 97.38K | |
| 03-Nov-22 4:27 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 01-Nov-22 | Private Sale (Planned) | 2,500 | $60.83 | $152,075.00 | (2%) 102.38K to 99.88K | |
| 05-Oct-22 5:14 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 03-Oct-22 | Private Sale (Planned) | 2,500 | $66.69 | $166,725.00 | (2%) 104.88K to 102.38K | |
| 02-Sep-22 4:22 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 01-Sep-22 | Private Sale (Planned) | 2,500 | $60.30 | $150,750.00 | (2%) 107.38K to 104.88K | |
| 02-Aug-22 4:18 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 01-Aug-22 | Private Sale (Planned) | 2,500 | $55.99 | $139,975.00 | (2%) 109.88K to 107.38K | |
| 02-Jun-22 6:24 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 01-Jun-22 | Market Sale (Planned) | 2,500 | $41.78 | $104,450.00 | (2%) 112.06K to 109.56K | (6%) |
| 03-May-22 7:56 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 02-May-22 | Sale (Planned) | 2,500 | $43.56 | $108,900.00 | (2%) 114.56K to 112.06K | |
| 03-May-22 7:56 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 21-Apr-22 | Disposition (other) | 1,875 | -- | -- | (2%) 116.44K to 114.56K | |
| 17-Mar-22 6:19 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 15-Mar-22 | Option Exercise | 7,000 | $4.31 | $30,170.00 | 6% 109.81K to 116.81K | |
| 17-Mar-22 6:19 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 15-Mar-22 | Planned Option Sale | 375 | $39.57 | $14,838.80 | (< 1%) 116.81K to 116.44K | |
| 02-Mar-22 6:15 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 01-Mar-22 | Market Sale (Planned) | 375 | $43.53 | $16,323.80 | (< 1%) 110.19K to 109.81K | (2%) |
| 24-Feb-22 4:33 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 23-Feb-22 | Option Exercise | 4,100 | $4.31 | $17,671.00 | 4% 106.09K to 110.19K | |
| 16-Feb-22 4:29 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 15-Feb-22 | Market Sale (Planned) | 375 | $45.43 | $17,036.20 | (< 1%) 106.46K to 106.09K | 2% |
| 15-Feb-22 4:59 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 14-Feb-22 | Option Exercise | 3,600 | $4.31 | $15,516.00 | 3% 102.86K to 106.46K | |
| 14-Feb-22 4:29 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 10-Feb-22 | Payment of Exercise | 705 | $47.12 | $33,219.60 | (< 1%) 103.57K to 102.86K | |
| 02-Feb-22 4:50 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 01-Feb-22 | Market Sale (Planned) | 375 | $40.58 | $15,217.50 | (< 1%) 103.94K to 103.57K | (10%) |
| 01-Feb-22 6:07 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 28-Jan-22 | Payment of Exercise | 650 | $38.59 | $25,083.50 | (< 1%) 104.59K to 103.94K | (15%) |
| 25-Jan-22 4:55 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 21-Jan-22 | Grant | 26,051 | -- | -- | 33% 78.54K to 104.59K | |
| 19-Jan-22 8:03 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 14-Jan-22 | Option Exercise | 3,400 | $4.31 | $14,654.00 | 5% 75.52K to 78.92K | |
| 19-Jan-22 8:03 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 14-Jan-22 | Planned Option Sale | 375 | $40.56 | $15,210.00 | (< 1%) 78.92K to 78.54K | |
| 14-Jan-22 4:57 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 12-Jan-22 | Option Exercise | 5,161 | $3.92 | $20,230.40 | 7% 70.35K to 75.52K | |
| 04-Jan-22 4:07 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 03-Jan-22 | Market Sale (Planned) | 375 | $47.31 | $17,741.20 | (< 1%) 70.73K to 70.35K | (3%) |
| 17-Dec-21 5:10 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 15-Dec-21 | Market Sale (Planned) | 375 | $42.88 | $16,080.00 | (< 1%) 71.1K to 70.73K | (5%) |
| 09-Dec-21 4:57 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 08-Dec-21 | Option Exercise | 7,000 | $3.76 | $26,320.00 | 11% 64.1K to 71.1K | |
| 03-Dec-21 4:00 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 01-Dec-21 | Market Sale (Planned) | 375 | $42.40 | $15,900.00 | (< 1%) 64.48K to 64.1K | (3%) |
| 17-Nov-21 5:02 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 15-Nov-21 | Market Sale (Planned) | 625 | $43.50 | $27,187.50 | (< 1%) 65.1K to 64.48K | (8%) |
| 02-Nov-21 4:01 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 01-Nov-21 | Market Sale (Planned) | 625 | $30.70 | $19,187.50 | (< 1%) 65.43K to 64.81K | (6%) |
| 15-Oct-21 4:02 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 14-Oct-21 | Market Sale (Planned) | 750 | $34.57 | $25,927.50 | (1%) 66.18K to 65.43K | (2%) |
| 05-Oct-21 4:16 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 01-Oct-21 | Market Sale (Planned) | 750 | $33.26 | $24,945.00 | (1%) 66.93K to 66.18K | < 1% |
| 29-Sep-21 9:48 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 28-Sep-21 | Option Exercise | 4,000 | $3.76 | $15,040.00 | 6% 62.93K to 66.93K | |
| 15-Jul-21 4:56 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 14-Jul-21 | Market Sale (Planned) | 500 | $64.68 | $32,340.00 | (< 1%) 63.68K to 63.18K | 3% |
| 09-Jul-21 3:59 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 08-Jul-21 | Market Sale (Planned) | 250 | $65.68 | $16,420.00 | (< 1%) 63.93K to 63.68K | < 1% |
| 29-Jun-21 4:58 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 28-Jun-21 | Option Exercise | 9,000 | $3.76 | $33,840.00 | 16% 54.93K to 63.93K | |
| 15-Jun-21 4:03 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 14-Jun-21 | Market Sale (Planned) | 500 | $61.84 | $30,920.00 | (< 1%) 55.43K to 54.93K | (5%) |
| 18-May-21 4:06 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 14-May-21 | Market Sale (Planned) | 500 | $45.39 | $22,695.00 | (< 1%) 55.93K to 55.43K | (25%) |
| 04-May-21 4:11 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 03-May-21 | Market Sale (Planned) | 600 | $50.73 | $30,438.00 | (1%) 56.21K to 55.61K | (12%) |
| 15-Apr-21 5:55 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 14-Apr-21 | Market Sale (Planned) | 500 | $42.82 | $21,410.00 | (< 1%) 56.71K to 56.21K | (33%) |
| 05-Apr-21 5:11 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 01-Apr-21 | Market Sale (Planned) | 600 | $43.41 | $26,046.00 | (1%) 57.31K to 56.71K | (31%) |
| 17-Mar-21 4:14 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 15-Mar-21 | Market Sale (Planned) | 500 | $46.77 | $23,385.00 | (< 1%) 57.81K to 57.31K | (22%) |
| 08-Mar-21 4:32 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 05-Mar-21 | Option Exercise | 5,000 | $3.20 | $16,000.00 | 9% 57.81K to 62.81K | |
| 08-Mar-21 4:32 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 05-Mar-21 | Market Option Sale | 5,000 | $48.62 | $243,075.00 | (8%) 62.81K to 57.81K | (17%) |
| 03-Mar-21 4:03 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 01-Mar-21 | Market Sale (Planned) | 600 | $48.58 | $29,148.00 | (1%) 58.41K to 57.81K | (17%) |
| 17-Feb-21 4:12 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 16-Feb-21 | Market Sale (Planned) | 500 | $46.00 | $23,000.00 | (< 1%) 58.91K to 58.41K | (24%) |
| 11-Feb-21 4:06 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 10-Feb-21 | Payment of Exercise | 688 | $47.72 | $32,831.40 | (1%) 59.6K to 58.91K | (19%) |
| 02-Feb-21 4:08 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 01-Feb-21 | Market Sale (Planned) | 600 | $44.00 | $26,400.00 | (< 1%) 60.2K to 59.6K | (29%) |
| 01-Feb-21 4:43 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 28-Jan-21 | Grant | 9,375 | -- | -- | 18% 50.83K to 60.2K | |
| 26-Jan-21 4:25 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 25-Jan-21 | Option Exercise | 15,000 | $3.63 | $54,440.00 | 42% 35.83K to 50.83K | |
| 15-Jan-21 4:10 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 14-Jan-21 | Market Sale (Planned) | 4,000 | $51.99 | $207,960.00 | (10%) 39.83K to 35.83K | (9%) |
| 05-Jan-21 4:21 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 04-Jan-21 | Market Sale (Planned) | 600 | $57.24 | $34,344.00 | (1%) 40.43K to 39.83K | < 1% |